cerca CERCA
Sabato 13 Agosto 2022
Aggiornato: 23:04
Temi caldi

global biotechnology company

comunicato stampa

Ichnos Sciences Appoints Sonia Quaratino, M.D., Ph.D., To Its Board Of Directors

NEW YORK, Nov. 9, 2021 /PRNewswire/ -- Ichnos Sciences Inc., a global biotechnology company developing innovative biologics in oncology and autoimmune diseases, announced that Sonia Quaratino, M.D., Ph.D., has been appointed as an independent member of its Board of Directors. Dr. Quaratino has over twenty-five years of experience in immunology research, clinical development at biotechnology and pharmaceutical companies, has served on multiple boards, and overseen research programs at leading acad...

comunicato stampa

Ichnos Sciences Welcomes Eric Feldman, M.D., as New Chief Medical Officer

NEW YORK, Nov. 8, 2021 /PRNewswire/ -- Ichnos Sciences Inc., a global biotechnology company developing innovative biologic treatments in oncology and autoimmune diseases, today announced the appointment of Eric J. Feldman, M.D., to the position of Chief Medical Officer (CMO), effective immediately.

ora in
Prima pagina
articoli
in Evidenza